George Soros is the famous stock market investor and speculator who is known for "breaking the Bank of England" in 1992. He is also the founder of the extremely successful Quantum Fund and the 80th-richest person in the world, according to Forbes, with a net worth of about $8.5 billion.
Not only do we like to piggyback investors such as Soros, but we also like stock picks that are confirmed by insiders. We believe this makes the stock a very favorable potential investment.
Although insiders may sell shares for various reasons, they don't normally purchase shares in their own company unless they are fairly certain about the future prospects.
With this in mind, we have set up a list of
list at Stockpickr.com. To check out his entire holdings, including
is far and away the Soros stock with the largest amount of insider buying.
Bon-Ton, which was founded in 1898, has over 280 department stores nationwide.
Two insiders have recently purchased 383,000 shares, showing a significant amount of confidence in the company.
Bon-Ton is also in the portfolio of
, a New York City-based hedge fund run by John Gordon and Arthur Byrnes. Deltec has an interesting portfolio, withsignificant holdings in South America and countries around the world, including in such stocks as
Uniao de Bancos Brasileiros
( UBB) and
Bon-Ton also shows up under Stockpickr.com's
High-Yield George Soros Stocks list because of its dividend, even if it's a small one. The highest-yielding stock on the list is
Another Soros stock with insider buying is
, which makes nucleic acid probe-based products used for the clinical diagnosis of diseases. Its products detect sexually transmitted diseases, tuberculosis, strep throat and pneumonia.
One of the directors, John W. Brown, made a direct purchase of $233,250 worth of shares in the company back in March. The stock is also owned by the
, which invests in stocks that are smaller than the largest company in the Russell 2000 Index. Emerald owns such stocks as
Gen-Probe is also listed in Stockpickr.com's
GrowthWith Controlled Risk portfolio.
You can see the
, which includes CVS, at Stockpickr.com.
And to get a breakdown on Soros' portfolio, check out
At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.
James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for
The Financial Times
and the author of
Trade Like a Hedge Fund
Trade Like Warren Buffett
. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;
to send him an email.
TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.